Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (451-460 of 587) with videos related to

Pageof 59
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Iron in the Parkinsonian substantia nigraM Gerlach, K Double, P Riederer, et al.
Experimental Neurology|November 26, 2003
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegenerationK L Double, G M Halliday, J Henderson, et al.
Journal of Neural Transmission. General Section|January 1, 1994
Organization of the human serotonin transporter geneK P Lesch, U Balling, J Gross, et al.
Psychiatry Research|January 30, 1999
Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patientsN Wodarz, C Rothenhöfer, R Fischer, et al.
Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.
Journal of Neural Transmission. Supplementum|April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseasesE Sofic, A Sapcanin, I Tahirovic, et al.
Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorderG Laux, W Classen, E Sofic, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communicationG Stöber, S Jatzke, A Heils, et al.
Journal of Neuroscience Research|August 1, 1996
U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transportersE Koutsilieri, J Kornhuber, H J Degen, et al.
Pageof 59

Showing results (451-460 of 587) with videos related to

Sort By:
Pageof 59
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Iron in the Parkinsonian substantia nigraM Gerlach, K Double, P Riederer, et al.
Experimental Neurology|November 26, 2003
The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegenerationK L Double, G M Halliday, J Henderson, et al.
Journal of Neural Transmission. General Section|January 1, 1994
Organization of the human serotonin transporter geneK P Lesch, U Balling, J Gross, et al.
Psychiatry Research|January 30, 1999
Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patientsN Wodarz, C Rothenhöfer, R Fischer, et al.
Advances in Neurology|January 1, 1987
Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenylP Riederer, C Konradi, V Schay, et al.
Journal of Neural Transmission. Supplementum|April 24, 2007
Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseasesE Sofic, A Sapcanin, I Tahirovic, et al.
Journal of Neurochemistry|February 1, 1989
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brainsP Riederer, E Sofic, W D Rausch, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorderG Laux, W Classen, E Sofic, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Insertion/deletion variant (-141C Ins/Del) in the 5' regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder. Short communicationG Stöber, S Jatzke, A Heils, et al.
Journal of Neuroscience Research|August 1, 1996
U-373 MG glioblastoma and IMR-32 neuroblastoma cell lines express the dopamine and vesicular monoamine transportersE Koutsilieri, J Kornhuber, H J Degen, et al.
Pageof 59